2018 September 26 - IDSA News

Read the last issue of IDSA News

Read the next issue of IDSA News

In Memoriam

Sydney Finegold, MD, FIDSA, Past President of IDSA, passed away on September 17 at age 97.

IDSA and HIVMA Members Keep Up Pressure on CMS to Delay Harmful E/M Payment Proposal

IDSA and HIVMA continue to urge members of Congress to ask the Centers for Medicare & Medicaid Services (CMS) to delay the implementation of the proposed E/M payment and documentation policies and to work with the medical community to develop an alternative that is more balanced and fair to both patients and providers.

Diversity, Inclusion & Equity Task Force Members Named

Among the recommendations of the Governance Task Force approved by the IDSA Board of Directors at its June meeting was the establishment of a Diversity, Inclusion and Equity (DI&E) Task Force.

Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.
Reviews in this issue: Saving SIRS? Discernment of Sepsis from Non-Infectious Syndromes in the ED, Current Epidemiology of Bacterial Infections in Young Infants, Cost and Length of Stay Savings with Molecular Testing for Tuberculosis among U.S. Inpatients

Congressional Funding Agreement Supports ID and HIV Programs

The House and Senate have announced an agreement on a final fiscal year 2019 Labor, Health and Human Services and Department of Defense appropriations bill.

IDSA to Participate in World AMR Congress

The fourth annual World Antimicrobial Resistance Congress will bring 150 speakers and 400 stakeholders to Washington, D.C., Oct. 25 and 26 to discuss critical challenges and opportunities to advance antibiotic and diagnostics development.

Commemorating 15 Years of PEPFAR, Examining Challenges that Remain

IDSA cosponsored a Congressional briefing commemorating 15 years of the President’s Emergency Plan for AIDS Relief (PEPFAR) and looking at the challenges that remain in achieving HIV epidemic control.

Updates from the CLSI Subcommittee on Susceptibility Testing

The Clinical Laboratory and Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing met in June. Amy Mathers, MD, D(ABMM), IDSA liaison for CLSI, provided the following clinically relevant updates from the meeting.

IDSA Advocates for Continued Patient Access to in vitro Diagnostics

IDSA has continued to be highly engaged in the ongoing policy discussions regarding regulation for laboratory developed tests (LDTs).

Playing JeoparIDy on Capitol Hill

Members of Congress play JeoparIDy at the Coalition for Health Funding Public Health Fair, which was held on Capitol Hill earlier this month.

Science Speaks

IDSA’s Science Speaks blog discussed the newest tuberculosis treatments in the United States, and the ramifications of global TB data.

IDSA & ID in the News

On a daily basis, IDSA spokespersons interview with media organizations across the country, providing facts, perspectives and important public health information about infectious diseases to the public.

ICYMI: What’s Hot on MyIDSA

Keep up with the latest information on the MyIDSA community boards.